薬物の経口投与は、特に糖尿病のような慢性疾患の患者にとって、最も受け入れやすく便利な投与経路と考えられています。経口インスリンを用いた治療には、患者のコンプライアンスの向上、迅速な肝インスリン化、末梢の高インスリン血症の回避、低血糖や体重増加などの副作用の回避などの利点があります。
世界の経口インスリン市場は、2019年から2020年の間に大幅に増加しており、今後4年間、すなわち2021年から2025年の間に驚異的に上昇すると予測されています。経口インスリン市場は、急速な都市化、医療費の高騰、糖尿病の有病率の増加、政府の有利な取り組み、注射用インスリンに対する経口インスリンの優位性などにより、増加すると予想されます。しかし、市場は、FDAの承認取得に関する不確実性、経口バイオアベイラビリティの低さなど、いくつかの課題に直面しています。
本レポートは、価値別などによる世界の経口インスリン市場の詳細な分析を提供します。また、次の地域を含む経口インスリン市場の地域分析を提供します；北アメリカ（アメリカ・メキシコ・カナダ）、ヨーロッパ（ドイツ・イギリス・フランス・イタリア・スペイン・その他のヨーロッパ）、アジア太平洋地域（中国・日本・インド・オーストラリア・韓国・その他のアジア太平洋地域）、および世界のその他の地域（ブラジル・サウジアラビア・南アフリカ・その他の国々）。さらに、経口インスリン市場へのCOVID-19（新型コロナウイルス感染症）の影響を詳細に分析します。
また、経口インスリン市場における重要な機会を評価し、本産業の成長を推進している要因および今後推進すると予測される要因を概説します。さらに、過去の成長パターン、成長推進要因、現在および将来の動向を考慮に入れて、2021～2025年における世界の経口インスリン市場の成長を予測します。
世界の経口インスリン市場は、少数の主要な市場企業で統合されています。さらに、財務状況や事業戦略など、Novo Nordisk A/S社、Oramed Pharmaceuticals Inc.社、vTv Therapeutics社、Diabetology Ltd.社を含む主要企業のプロファイルを提供します。
目次
1. Executive Summary
2. Introduction
2.1 Diabetes Mellitus: An Overview
2.2 Insulin: An Overview
2.2.1 Kinds of Insulin Formulations
2.3 Oral Insulin: An Overview
2.3.1 Types of Oral Insulin
2.3.2 Advantages of Oral Insulin Treatment
2.4 Oral Insulin Segmentation: An Overview
2.4.1 Oral Insulin Segmentation
3. Global Market Analysis
3.1 Global Oral Insulin Market: An Analysis
3.1.1 Global Oral Insulin Market by Value
3.1.2 Global Oral Insulin Market by Region (North America, Europe, Asia Pacific, and Rest of World)
4. Regional Market Analysis
4.1 North America Oral Insulin Market: An Analysis
4.1.1 North America Oral Insulin Market by Value
4.1.2 North America Oral Insulin Market by Region (The US, Mexico, and Canada)
4.1.3 The US Oral Insulin Market by Value
4.1.4 Canada Oral Insulin Market by Value
4.1.5 Mexico Oral Insulin Market by Value
4.2 Europe Oral Insulin Market: An Analysis
4.2.1 Europe Oral Insulin Market by Value
4.2.2 Europe Oral Insulin Market by Region (Germany, UK, France, Italy, Spain, and Rest of Europe)
4.2.3 Germany Oral Insulin Market by Value
4.2.4 UK Oral Insulin Market by Value
4.2.5 France Oral Insulin Market by Value
4.2.6 Italy Oral Insulin Market by Value
4.2.7 Spain Oral Insulin Market by Value
4.2.8 Rest of Europe Oral Insulin Market by Value
4.3 Asia Pacific Oral Insulin Market: An Analysis
4.3.1 Asia Pacific Oral Insulin Market by Value
4.3.2 Asia Pacific Oral Insulin Market by Region (China, Japan, India, Australia, South Korea and Rest of Asia Pacific)
4.3.3 China Oral Insulin Market by Value
4.3.4 Japan Oral Insulin Market by Value
4.3.5 India Oral Insulin Market by Value
4.3.6 Australia Oral Insulin Market by Value
4.3.7 South Korea Oral Insulin Market by Value
4.3.8 Rest of Asia Pacific Oral Insulin Market by Value
4.4 ROW Oral Insulin Market: An Analysis
4.4.1 ROW Oral Insulin Market by Value
4.4.2 ROW Oral Insulin Market by Region (Brazil, Saudi Arabia, South Africa, and ROW countries)
4.4.3 Brazil Oral Insulin Market by Value
4.4.4 Saudi Arabia Oral Insulin Market by Value
4.4.5 South Africa Oral Insulin Market by Value
4.4.6 ROW Countries Oral Insulin Market by Value
5. Impact of COVID-19
5.1 Impact of COVID-19
5.1.1 Impact of COVID-19 on Healthcare Sector
5.1.2 Impact of COVID-19 on Diabetic Patients
5.1.3 Impact of COVID-19 on Oral Insulin
6. Market Dynamics
6.1 Growth Driver
6.1.1 Rapid Urbanization
6.1.2 Increasing Prevalence of Diabetes
6.1.3 Escalating Healthcare Spending
6.1.4 Favorable Government Initiatives
6.1.5 Advantages of Oral Insulin over Injectable Insulin
6.2 Challenges
6.2.1 Uncertainty around Getting the FDA Approval
6.2.2 Low Oral Bioavailability
6.3 Market Trends
6.3.1 Increasing Demand for Oral Spray
6.3.2 Growing Use of Oral Insulin Capsule for the Treatment of Nonalcoholic Steatohepatitis (NASH)
6.3.3 Innovations in the Delivery of Oral Insulin
7. Competitive Landscape
7.1 Global Oral Insulin Market Players: A Financial Comparison
7.2 Global Oral Insulin Market Players by Oral Drugs-related Clinical Trials
8. Company Profiles
8.1 Novo Nordisk A/S
8.1.1 Business Overview
8.1.2 Financial Overview
8.1.3 Business Strategy
8.2 Oramed Pharmaceuticals Inc.
8.2.1 Business Overview
8.2.2 Financial Overview
8.2.3 Business Strategy
8.3 vTv Therapeutics
8.3.1 Business Overview
8.3.2 Financial Overview
8.3.3 Business Strategy
8.4 Diabetology Ltd
8.4.1 Business Overview
List of Figures
Figure 1: Kinds of Insulin Formulations
Figure 2: Types of Oral Insulin
Figure 3: Oral Insulin Segmentation
Figure 4: Global Oral Insulin Market by Value; 2019-2020 (US$ Billion)
Figure 5: Global Oral Insulin Market by Value; 2021-2025 (US$ Billion)
Figure 6: Global Oral Insulin Market by Region; 2020 (Percentage, %)
Figure 7: North America Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 8: North America Oral Insulin Market by Value; 2021-2025 (US$ Billion)
Figure 9: North America Oral Insulin Market by Region; 2020 (Percentage, %)
Figure 10: The US Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 11: The US Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 12: Canada Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 13: Canada Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 14: Mexico Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 15: Mexico Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 16: Europe Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 17: Europe Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 18: Europe Oral Insulin Market by Region; 2020 (Percentage, %)
Figure 19: Germany Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 20: Germany Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 21: UK Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 22: UK Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 23: France Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 24: France Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 25: Italy Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 26: Italy Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 27: Spain Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 28: Spain Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 29: Rest of Europe Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 30: Rest of Europe Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 31: Asia Pacific Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 32: Asia Pacific Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 33: Asia Pacific Oral Insulin Market by Region; 2020 (Percentage, %)
Figure 34: China Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 35: China Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 36: Japan Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 37: Japan Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 38: India Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 39: India Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 40: Australia Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 41: Australia Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 42: South Korea Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 43: South Korea Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 44: Rest of Asia Pacific Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 45: Rest of Asia Pacific Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 46: ROW Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 47: ROW Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 48: ROW Oral Insulin Market by Region; 2020 (Percentage, %)
Figure 49: Brazil Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 50: Brazil Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 51: Saudi Arabia Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 52: Saudi Arabia Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 53: South Africa Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 54: South Africa Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 55: ROW Countries Oral Insulin Market by Value; 2019-2020 (US$ Million)
Figure 56: ROW Countries Oral Insulin Market by Value; 2021-2025 (US$ Million)
Figure 57: Global Urban Population by Group of Economies; 2014-2050 (Million)
Figure 58: Global Number of People Suffering from Diabetes; 2011-2030 (Million)
Figure 59: Global Healthcare Spending; 2017-2022 (US$ Billion)
Figure 60: Novo Nordisk A/S Net Sales; 2016-2020 (US$ Billion)
Figure 61: Novo Nordisk A/S Net Sales by Segments; 2020 (Percentage, %)
Figure 62: Novo Nordisk A/S Net Sales by Region; 2020 (Percentage, %)
Figure 63: Oramed Pharmaceuticals Inc. Revenues; 2017-2020 (US$ Thousand)
Figure 64: vTv Therapeutics Revenue; 2018-2020 (US$ Million)
Table 1: Global Oral Insulin Market Players: A Financial Comparison; 2020
Table 2: Global Oral Insulin Market Players by Oral Drugs-related Clinical Trials; 2019
